Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion type Assertion NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_head.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion description "[We aimed to assess the efficacy and safety of olaparib for treatment of advanced ovarian cancer in patients with BRCA1 or BRCA2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_provenance.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion evidence source_evidence_literature NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_provenance.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion SIO_000772 20609468 NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_provenance.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion wasDerivedFrom gad-20150221 NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_provenance.
- NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_assertion wasGeneratedBy ECO_0000203 NP180730.RACuhbsnSZVsIeHzEAzdFvnCmgxqGg1NboUL2Dy-PSQVc130_provenance.